TG Therapeutics.

No events began in the chosen period. Widen it, or reset.

• FDA Structural
  AtriCure, Inc. reported revenue via NASDAQ and received FDA 510(k) clearance for its device.
  Moves TG Therapeutics

  02:45
• Securities and Exchange Commission Structural
  Kinder Morgan filed reports with the SEC while Amundi increased its stock holdings in the company.
  Moves TG Therapeutics

  13:17
• Royal Bank of Canada Transactional
  Multiple financial firms issued rating and price target updates on November 4, 2026.
  Moves TG Therapeutics

  14:11
• Switzerland Shared context
  The Swiss government, via Guy Parmelin, waived medical expense reimbursement costs previously attempted by the FSIO from the Italian health service.
  Moves TG Therapeutics

  13:59
• MarketBeat Mentioned together
  Lifeway Foods and J & J Snack Foods, both small-cap consumer staples, are listed on Nasdaq and are receiving analyst ratings from MarketBeat.
  Moves TG Therapeutics

  13:40

• Neuraxpharm Operational

  Neuraxpharm and TG Therapeutics partnered for the global commercialization and expansion of the drug Briumvi.

  SpeculativeAug 5
  TG Therapeutics → Neuraxpharm

  Neuraxpharm → TG Therapeutics
• FDA Structural

  TG Therapeutics' ability to market its products is structurally dependent on receiving regulatory approval from the FDA.

  SpeculativeSep 4
  TG Therapeutics → FDA

  FDA → TG Therapeutics
• Securities and Exchange Commission Structural

  TG Therapeutics is required to file regulatory reports and disclosures with the Securities and Exchange Commission.

  Well supportedJul 25
  TG Therapeutics → Securities and Exchange Commission

  Securities and Exchange Commission → TG Therapeutics
• PDT Partners Transactional

  PDT Partners acquired a new stock position in TG Therapeutics.

  Some supportAug 27
  TG Therapeutics → PDT Partners

  PDT Partners → TG Therapeutics
• Lawrence Steinman Operational

  Lawrence Steinman led the clinical trials for TG Therapeutics.

  SpeculativeMay 30
  TG Therapeutics → Lawrence Steinman

  Lawrence Steinman → TG Therapeutics
• Royal Bank of Canada Transactional

  The relationship involves an increased institutional stake in the company stock.

  Some supportJul 14
  TG Therapeutics → Royal Bank of Canada

  Royal Bank of Canada → TG Therapeutics
• Switzerland Shared context

  TG Therapeutics is operating and receiving regulatory approval within Switzerland.

  SpeculativeAug 28
  TG Therapeutics → Switzerland

  Switzerland → TG Therapeutics
• MarketBeat Mentioned together

  MarketBeat provides informational coverage by listing TG Therapeutics as a stock to watch.

  Some supportAug 3
  TG Therapeutics → MarketBeat

  MarketBeat → TG Therapeutics